U.S. CDMO Capacity
More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand
Pharma's Almanac
PAO-06-26-PA-18Jun 22, 2026
Oral mAbs
Oral Delivery of Monoclonal Antibodies: The Pursuit Continues
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-04-26-PA-05Apr 7, 2026
Spray Drying
From Formulation Tool to Manufacturing Strategy: The Evolving Role of Spray Drying
Nick Hodgson
Codis
PAO-03-26-CL-04Mar 11, 2026
Distribution
Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada
Ingredients + Specialties from Univar Solutions
PR-02-26-07Feb 25, 2026
Drug Product
State of the Industry 2026 Virtual Panel: Drug Product
Nice Insight
PAO-26-SOTI-05Feb 9, 2026
Drug Delivery
When Drug Delivery Fails at Tech Transfer
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-13Jan 13, 2026
OSD
Technologies Enabling Personalized and Patient-Specific Oral Solid Dosage Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-25-NI-02Nov 11, 2025
GLP-1
Bridging Boundaries in the GLP-1 Era: Pharma, Nutra, and Food Solutions
Aaron Lee; Jessica Zhang
Ingredients + Specialties from Univar Solutions
PAO-10-25-CL-01Oct 7, 2025
Minitablets
Minitablets: Enhancing Safety and Palatability for Pediatric Medicines
Gus LaBella
Mikart
PAO-09-24-CL-01Aug 30, 2024
Developability
Assessing Developability and Designing Advanceable Formulations from the Start
Nazar Elkarim, Ph.D.
Mikart
PAO-09-24-CL-02Aug 26, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09Feb 26, 2024
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
William Kazimier
Tedor Pharma Services
PAO-09-23-CL-08Jan 11, 2024
Formulation
Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms
Gus LaBella
Mikart
PAO-09-23-CL-04Oct 3, 2023
Sweeteners
High-Intensity Sweeteners for Taste Optimization
Almut von der Brelie
MilliporeSigma
PAO-11-022-CL-12Nov 28, 2022
OSD and Liquid
Reshoring Manufacturing and Targeted, Specialty Medicines
Mikart
PAO-05-22-R250-05May 17, 2022
Advanced Excipients
How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs
Daniel Joseph Price, Ph.D.
MilliporeSigma
PAO-04-022-CL-07Apr 27, 2022
Migraine
Biohaven Announces NURTEC® ODT Receives First Global Approval Outside the U.S. For Prevention of Migraine
Biohaven
PR-M12-21-01Dec 13, 2021
Streamlining OSD Operations from Tableting through Serialization
Richard Walkup
Avara Pharmaceutical Services
PA789Oct 21, 2021
Tablet Coating
An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility
Thomas Kipping, Ph.D.
MilliporeSigma
PAO-09-21-CL-06Sep 14, 2021
Solving the Patient-Centric Formulation Riddle
Beau Garrett
Tapemark
PA806Sep 9, 2021